REJUVXL Trademark

Trademark Overview


On Wednesday, September 20, 2023, a trademark application was filed for REJUVXL with the United States Patent and Trademark Office. The USPTO has given the REJUVXL trademark a serial number of 98189228. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, March 26, 2025. This trademark is owned by AION Healthspan, Inc.. The REJUVXL trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Cell therapy preparation in the nature of cells for medical and clinical use; cell therapy preparation in the nature of cryopreserved cells for medical and clinical use; cell therapy preparation in the nature of cell suspension being living cells for medical and clinical use; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for injection for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells, for infusion for medical and clinical use for treating kidney disease; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for treating chronic diseases such as chronic kidney disease, inflammatory diseases such as lung disease, immune-mediated conditions such as autoimmune disease or graft-versus-host disease, degenerative diseases such as neurodegenerative diseases; cell therapy prep...

Cell therapy preparation in the nature of cells for development use, other than for medical or veterinary purposes

Medical services; medical treatment using cultured cells; medical treatment protocol that includes administration of living cells; medical treatment, namely, injection of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment, namely, infusion of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment namely injection or infusion or implantation of living cells in combination with induction and or maintenance treatment with vitamins, protective molecules, and or pharmacological agents

Medical and scientific research and development in the field of cell therapy, regenerative medicine and healthspan medicine; cell therapy preparation in the nature of testing for research, development, engineering and testing services in the fields of immunopharmaceuticals, immunomodulators
rejuvxl

General Information


Serial Number98189228
Word MarkREJUVXL
Filing DateWednesday, September 20, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, March 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCell therapy preparation in the nature of cells for medical and clinical use; cell therapy preparation in the nature of cryopreserved cells for medical and clinical use; cell therapy preparation in the nature of cell suspension being living cells for medical and clinical use; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for injection for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells, for infusion for medical and clinical use for treating kidney disease; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for treating chronic diseases such as chronic kidney disease, inflammatory diseases such as lung disease, immune-mediated conditions such as autoimmune disease or graft-versus-host disease, degenerative diseases such as neurodegenerative diseases; cell therapy preparation in the nature of cell clusters being living cells clusters for medical and clinical use; cell therapy preparation in the nature of tissue being biological tissue cultures for medical and clinical use; therapeutic preparation in the nature of cell derivatives being biological materials derived from cells, namely extracellular vesicles, secretome, conditioned media, soluble factors, membrane fragments, or extracellular matrix for medical and clinical use; cell therapy preparation in the nature of pharmaceutical preparations comprised of molecules for combination with cell therapy for medical and clinical use for treating kidney disease; cell therapy preparation in the nature of pharmaceutical preparations comprised of molecules for combination with cells for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation in the nature of pharmaceutical preparations comprised of supramolecular complexes in combination with cells for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation of cell components being mitochondria or vesicles for medical and clinical use
Goods and ServicesCell therapy preparation in the nature of cells for development use, other than for medical or veterinary purposes
Goods and ServicesMedical services; medical treatment using cultured cells; medical treatment protocol that includes administration of living cells; medical treatment, namely, injection of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment, namely, infusion of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment namely injection or infusion or implantation of living cells in combination with induction and or maintenance treatment with vitamins, protective molecules, and or pharmacological agents
Goods and ServicesMedical and scientific research and development in the field of cell therapy, regenerative medicine and healthspan medicine; cell therapy preparation in the nature of testing for research, development, engineering and testing services in the fields of immunopharmaceuticals, immunomodulators

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, March 4, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 6, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 6, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAION Healthspan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33137

Trademark Events


Event DateEvent Description
Saturday, September 23, 2023NEW APPLICATION ENTERED
Tuesday, May 14, 2024NON-FINAL ACTION WRITTEN
Tuesday, May 14, 2024ASSIGNED TO EXAMINER
Tuesday, May 14, 2024NON-FINAL ACTION E-MAILED
Friday, October 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 9, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 18, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, July 9, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 4, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, November 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, March 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 4, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 26, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, March 26, 2025FINAL REFUSAL WRITTEN
Wednesday, March 26, 2025FINAL REFUSAL E-MAILED
Monday, March 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED